Therapies for children with cerebral palsy (CP) often fail to address essential components of early rehabilitation: intensity, child initiation, and an embodied approach. Sitting Together And Reaching To Play (START-Play) addresses these issues while incorporating intensive family involvement to maximize therapeutic dosage. While START-Play was developed and tested on children aged 7–16 months with motor delays, the theoretical construct can be applied to intervention in children of broader ages and skills levels. This study quantifies the impact of a broader STARTPlay intervention combined with Botulinum toxin-A (BoNT-A) and phenol on the developmental trajectory of a 24 month-old child with bilateral spastic CP. In this AB +1 study, A con...
Introduction: Cerebral palsy (CP) is a group of disorders that affect muscle movement, tone and coor...
BACKGROUND AND PURPOSE: Children with cerebral palsy (CP) in Gross Motor Function Classification Sys...
Cerebral palsy (CP) affects around every one in 500 children born. It isn’t a particular illness or ...
Therapies for children with cerebral palsy (CP) often fail to address essential components of early ...
Background: The average age for the diagnosis of cerebral palsy (CP) is 19 months. Recent neuroplast...
Backgound: Cerebral Palsy (CP) is a heterogeneous disorder in which movement and posture are always...
Abstract Background Use of Botulinum toxin-A (BoNT-A) for treatment of upper limb spasticity in chil...
Introduction. Patients with cerebral palsy (CP) present mobility limitations altering their activity...
OBJECTIVE: Our objective was to evaluate the efficacy of the Sitting Together and Reaching to Play (...
For children with moderate or severe cerebral palsy (CP), a foundational early goal is independent s...
BACKGROUND: Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equi...
Objective. Our objective was to evaluate the efficacy of the Sitting Together and Reaching to Play (...
Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy,...
Background: For children with unilateral spastic cerebral palsy (USCP), activities in daily life pos...
Aims: To examine the differences in efficacy of home-based constraint-induced therapy (CIT) on funct...
Introduction: Cerebral palsy (CP) is a group of disorders that affect muscle movement, tone and coor...
BACKGROUND AND PURPOSE: Children with cerebral palsy (CP) in Gross Motor Function Classification Sys...
Cerebral palsy (CP) affects around every one in 500 children born. It isn’t a particular illness or ...
Therapies for children with cerebral palsy (CP) often fail to address essential components of early ...
Background: The average age for the diagnosis of cerebral palsy (CP) is 19 months. Recent neuroplast...
Backgound: Cerebral Palsy (CP) is a heterogeneous disorder in which movement and posture are always...
Abstract Background Use of Botulinum toxin-A (BoNT-A) for treatment of upper limb spasticity in chil...
Introduction. Patients with cerebral palsy (CP) present mobility limitations altering their activity...
OBJECTIVE: Our objective was to evaluate the efficacy of the Sitting Together and Reaching to Play (...
For children with moderate or severe cerebral palsy (CP), a foundational early goal is independent s...
BACKGROUND: Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equi...
Objective. Our objective was to evaluate the efficacy of the Sitting Together and Reaching to Play (...
Objective: Botulinum toxin (BoNT-A) is widely used in combined treatment for spastic cerebral palsy,...
Background: For children with unilateral spastic cerebral palsy (USCP), activities in daily life pos...
Aims: To examine the differences in efficacy of home-based constraint-induced therapy (CIT) on funct...
Introduction: Cerebral palsy (CP) is a group of disorders that affect muscle movement, tone and coor...
BACKGROUND AND PURPOSE: Children with cerebral palsy (CP) in Gross Motor Function Classification Sys...
Cerebral palsy (CP) affects around every one in 500 children born. It isn’t a particular illness or ...